TearScience Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:TearScience Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10331
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TearScience Inc (TearScience) is a medical device company that carries out identifying, diagnosing, and treating meibomian gland dysfunction (MGD). The company conducts early detection and treatment of prevalent, chronic, and progressive MGD. It offers LipiFlow thermal pulsation system, a single-use sterile device that delivers automated therapeutic energies to meibomian gland while protecting the delicate structures of the patient’s eye. TearScience also develops LipiScan, a gland imager that allows eye care professionals to evaluate meibomian glands in practices; and LipiView II, an ocular surface interferometer with dynamic meibomian imaging measures lipid layer thickness with nanometer accuracy. The company markets its products across Canada, Australia, New Zealand, the US, and others. TearScience is headquartered in Morrisville, North Carolina, the US.

TearScience Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TearScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearScience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TearScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearScience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
TearScience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TearScience Inc, Medical Equipment, Deal Details 10
Venture Financing 10
TearScience Raises Funds through Series D Financing 10
TearScience Raises Up To US$70 Million In Venture Financing 11
Equity Offering 12
TearScience, Developer of Medical Devices, Plans For IPO 12
Asset Transactions 13
Shinagawa Lasik Acquires TearScience Dry Eye System From TearScience 13
Acquisition 14
Abbott Medical Optics Acquires TearScience 14
TearScience Inc – Key Competitors 15
TearScience Inc – Key Employees 16
TearScience Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
TearScience Inc, Medical Equipment, Key Facts 2
TearScience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
TearScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearScience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TearScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearScience Inc, Deals By Market, 2012 to YTD 2018 8
TearScience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TearScience Raises Funds through Series D Financing 10
TearScience Raises Up To US$70 Million In Venture Financing 11
TearScience, Developer of Medical Devices, Plans For IPO 12
Shinagawa Lasik Acquires TearScience Dry Eye System From TearScience 13
Abbott Medical Optics Acquires TearScience 14
TearScience Inc, Key Competitors 15
TearScience Inc, Key Employees 16

List of Figures
TearScience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
TearScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
TearScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
TearScience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
TearScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearScience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
TearScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearScience Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[TearScience Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • N V Nederlandse Gasunie:企業の戦略・SWOT・財務情報
    N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report Summary N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Qatar Airways Group Q.C.S.C.:企業の戦略・SWOT・財務情報
    Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report Summary Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Drax Group Plc (DRX):電力:M&Aディール及び事業提携情報
    Summary Drax Group plc (Drax) is a biomass-fuelled electricity generator, which generates electricity from coal and biomass. It operates across three principal areas of activity, electricity generation; electricity sales to business customers; and compressed wood pellet production. The company opera …
  • Shire Plc (SHP):企業の財務・戦略的SWOT分析
    Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Emisphere Technologies Inc (EMIS):企業の戦略的SWOT分析
    Emisphere Technologies Inc (EMIS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Lotus Bakeries NV:企業の戦略・SWOT・財務情報
    Lotus Bakeries NV - Strategy, SWOT and Corporate Finance Report Summary Lotus Bakeries NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PQ Group Holdings Inc (PQG):企業の財務・戦略的SWOT分析
    PQ Group Holdings Inc (PQG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • GBST Holdings Limited (GBT):企業の財務・戦略的SWOT分析
    GBST Holdings Limited (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SmarTone Telecommunications Holdings Ltd (315):企業の財務・戦略的SWOT分析
    SmarTone Telecommunications Holdings Ltd (315) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Jadason Enterprises Ltd (J03):企業の財務・戦略的SWOT分析
    Jadason Enterprises Ltd (J03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Carraro Spa:戦略・SWOT・企業財務分析
    Carraro Spa - Strategy, SWOT and Corporate Finance Report Summary Carraro Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • National Research Corp (NRCIB):企業の財務・戦略的SWOT分析
    Summary National Research Corp (NRC) is a healthcare organization that provides market insight solutions. The company’s solutions include experience collection, market insights, transparency of experience data and governance. It offers market insights solutions that allow the tracking of awareness, …
  • Shenzhen Jinjia Group Co., Ltd.:戦略・SWOT・企業財務分析
    Shenzhen Jinjia Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shenzhen Jinjia Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Hanesbrands Inc (HBI):企業の財務・戦略的SWOT分析
    Hanesbrands Inc (HBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Abreos Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Walchandnagar Industries Ltd:企業の戦略・SWOT・財務情報
    Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Infant Bacterial Therapeutics AB (IBT B):企業の財務・戦略的SWOT分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • Singapore Press Holdings Ltd (T39)
    Singapore Press Holdings Ltd (T39) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • FuelCell Energy Inc (FCEL):企業の財務・戦略的SWOT分析
    FuelCell Energy Inc (FCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆